(Q34290347)

1 August 2017

title

Stem cell educator therapy and induction of immune balance (English)

1 reference

1 August 2017

Yong Zhao

1

1 reference

1 August 2017

publication date

1 October 2012

1 reference

1 August 2017

published in

Current diabetes report

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

517-523

1 reference

Human cord blood stem cells and the journey to a cure for type 1 diabetes

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Genetics, pathogenesis and clinical interventions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Immune cell crosstalk in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Human umbilical cord blood-derived f-macrophages retain pluripotentiality after thrombopoietin expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Mesenchymal stem cell therapy: Two steps forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Ex vivo expansion of human mesenchymal stem cells in defined serum-free media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Assessing the safety of stem cell therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Mesenchymal stromal cells: new directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

TGF-beta: a master of all T cell trades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Mesenchymal Stem Cells: Mechanisms of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Stem cell therapy for type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Pancreatic β-cell neogenesis by direct conversion from mature α-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Animal models of human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0308-1

Arresting type 1 diabetes after diagnosis: GAD is not enough

21 January 2018

1 reference

12 December 2020

Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model

1 reference

12 December 2020

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

1 reference

12 December 2020

Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling

1 reference

12 December 2020

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

12 December 2020

A unique human blood-derived cell population displays high potential for producing insulin

1 reference

12 December 2020

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

1 reference

12 December 2020

Stem cell therapies for type 1 diabetes mellitus

1 reference

12 December 2020

Physiological and pathological consequences of identification of very small embryonic like (VSEL) stem cells in adult bone marrow.

1 reference

12 December 2020

10.1007/S11892-012-0308-1

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1005456338

0 references

1 reference